This is a Phase 4 clinical trial to determine the effectiveness of using atomoxetine in children age 10 to 16 who have ADHD as well as dyslexia. The study will assess the effect of atomoxetine on basic reading skills,working memory, social, emotional, cognitive, educational, and affiliative functioning. This study is currently recruiting patients.
Read moreIf you take medication for ADHD symptoms, chances are you use a stimulant medication such as Adderall, Ritalin or Concerta. These types of... Read more »
Stimulant medications are often used to treat ADHD but it is estimated that between 10 percent and 20 percent of people with ADHD are not... Read more »
In the majority of cases when women contact me to discuss and get support after receiving an ADHD diagnosis, more often than not, they... Read more »
Over the years there has been conflicting information on how, why and even if, certain foods or drinks impact the effectiveness of ADHD... Read more »
During pregnancy, women must make choices based not only on their own needs, but on the needs of their unborn child. For most women, this... Read more »
A new British study has shown that children with attention-deficit hyperactivity disorder (ADHD) who take Strattera (atomoxetine) to control the... Read more »
Data from 13 clinical trials has shown that after two years on Strattera, teens with attention-deficit/hyperactivity disorder (ADHD) continue to show... Read more »
Source: First DataBank
Generic Name: ATOMOXETINE - ORAL Pronounced: (at-oh-MOX-eh-teen) Uses Atomoxetine is used to treat attention-deficit hyperactivity disorder... Read more »
Health Canada has received two reports linking the attention-deficit/hyperactivity disorder (ADHD) drug Strattera with tics in children. In one case,... Read more »
The U.S. Food and Drug Administration (FDA) has granted approval for Atomoxetine HCl--a generic version of the ADHD medication Strattera. The FDA... Read more »